Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Jennifer L. Guerriero(Brigham and Women's Hospital), Sandro Santagata(Harvard University), Melissa E. Hughes(Dana-Farber Cancer Institute), Otto Metzger(Dana-Farber Cancer Institute), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Madeline G Townsend(Brigham and Women's Hospital), Nancy U. Lin(Dana-Farber Cancer Institute), Jia‐Ren Lin(Harvard University), Krishan Taneja(Brigham and Women's Hospital), Stuart J. Schnitt(Brigham and Women's Hospital), Peter K. Sorger(Harvard University Press), Deborah Dillon(Harvard University), Sara M. Tolaney(Harvard University), Kenichi Shimada(Harvard University), Ricardo Pastorello(Dana-Farber Cancer Institute), Alyssa Patterson(Dana-Farber Brigham Cancer Center), Ziming Du(Fuyang City People's Hospital), Siyang Ren(Dana-Farber Cancer Institute), Kelly Zheng(Brigham and Women's Hospital), Nabihah Tayob(Dana-Farber Cancer Institute), Shaolin Mei(Harvard University)
npj Breast Cancer
January 2, 2024
Cited by 10


Related Papers